Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Safety and Efficacy of Ivermectin in Rosacea
NCT02795117Phase 3Completed
- Sponsor
- Padagis
- Start
- May 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ivermectin in papulopustular rosacea, sponsored by Padagis. Started May 2016; status: completed.
02
Drugs
ivermectin
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT02795117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02795117.